Skip Links
  • Skip to Navigation
  • Skip to Content
Clinical Guidelines Network
Personal tools
  • Create account
  • Log in
Navigation
  • Home
  • About
    • About the clinical guidelines
    • Declaring and dealing with competing interests
    • Frequently asked questions
    • Guideline journal articles
  • Cancer Council guidelines
    • Barrett's Oesophagus
    • Bowel cancer
      • Colorectal cancer
      • Surveillance colonoscopy
    • Endometrial cancer
    • Cervical cancer screening
    • Lung cancer
      • Lung cancer prevention & diagnosis
      • Lung cancer treatment
    • Prostate cancer
      • Advanced prostate cancer
      • PSA testing
    • Sarcoma
    • Skin cancer
      • Melanoma
      • Keratinocyte cancer (non-melanoma)
    • Pain management
    • Archive of CCA guidelines
  • COSA guidelines
    • Adolescents and Young Adult (AYA) guidelines
      • AYA cancer fertility preservation
      • AYA early cancer detection
      • AYA psychosocial management
    • Cancer therapy medication safety
    • Gastroenteropancreatic neuroendocrine tumours
    • Head & neck cancer nutrition
    • Teleoncology
  • National Cancer Prevention Policy
Social links
Page actions
  • View
  • View form
  • Code
  • History
 
  • Refresh
  • What links here
  • Related changes
  • Special pages
  • Permanent link
  • Page information
  • Export to PDF
  • Browse properties

Citation:Brierley JD, Gospodarowicz MK, Wittekind C 2017

From Clinical Guidelines Wiki

Citation


Brierley JD, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours, 8th Edition. Wiley-Blackwell; 2017.



Critical appraisals

  • Assign a critical appraisal


Compare quality appraisals for each clinical question

Cited by

  1. 6.1 Prognosis of basal cell carcinoma
  2. 6.2 Prognosis of cutaneous squamous cell carcinoma
  3. 8.1 Radiotherapy with or without surgical treatment for keratinocyte cancer
  4. 8.2 Radiotherapy for basal cell carcinoma
  5. 8.3 Radiotherapy for cutaneous squamous cell carcinoma
  6. 8.4 Radiotherapy for regional (nodal) metastatic disease (non-distant)
  7. 8.5 Radiotherapy for actinic keratosis and cutaneous squamous cell carcinoma in situ
  8. Glossary and abbreviations
  9. Introduction


Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Brierley_JD,_Gospodarowicz_MK,_Wittekind_C_2017&oldid=199621"